Literature DB >> 21704005

Astrocyte-derived thrombospondin-2 is critical for the repair of the blood-brain barrier.

Weiming Tian1, Andrew Sawyer, Feriha B Kocaoglu, Themis R Kyriakides.   

Abstract

Thrombospondin (TSP)-2-null mice have an altered brain foreign body response (FBR) characterized by increases in inflammation, extracellular matrix deposition, and leakage of the blood-brain barrier (BBB). In the present study, we investigated the role of TSP-2 in BBB repair during the brain FBR to mixed cellulose ester filters implanted in the cortex of wild-type (WT) and TSP-2-null mice for 2 days to 8 weeks. Histological and immunohistochemical analysis revealed enhanced and prolonged neuroinflammation in TSP-2-null mice up to 8 weeks after implantation. In addition, recovery of the BBB was compromised and was associated with increased gelatinolytic activity and low levels of collagen type IV in the basement membranes of TSP-2-null blood vessels. An analysis of protein extracts from implantation sites revealed elevated levels of matrix metalloproteinase (MMP)-2 and MMP-9 in TSP-2-null brains. TSP-2-null astrocytes secreted higher levels of both MMPs in vitro compared with their WT counterparts. Furthermore, TSP-2-null astrocytes were deficient in supporting the recovery of barrier function in WT endothelial cells. Finally, Western blot analysis of astrocytes and brain endothelial cells revealed TSP-2 expression only in the former. Taken together, our observations suggest that astrocyte-derived TSP-2 is critical for the maintenance of physiological MMP-2 and MMP-9 levels during the FBR and contributes to the repair of the BBB.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704005      PMCID: PMC3157184          DOI: 10.1016/j.ajpath.2011.05.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  What is the blood-brain barrier (not)?

Authors:  Ingo Bechmann; Ian Galea; V Hugh Perry
Journal:  Trends Immunol       Date:  2006-11-30       Impact factor: 16.687

2.  Proteolysis of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect and matrix abnormalities in thrombospondin-2-null fibroblasts and mice.

Authors:  Azin Agah; Themis R Kyriakides; Paul Bornstein
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

3.  Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice.

Authors:  T R Kyriakides; Y H Zhu; Z Yang; G Huynh; P Bornstein
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

4.  Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis.

Authors:  Karen S Christopherson; Erik M Ullian; Caleb C A Stokes; Christine E Mullowney; Johannes W Hell; Azin Agah; Jack Lawler; Deane F Mosher; Paul Bornstein; Ben A Barres
Journal:  Cell       Date:  2005-02-11       Impact factor: 41.582

5.  Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.

Authors:  E A van Vliet; S da Costa Araújo; S Redeker; R van Schaik; E Aronica; J A Gorter
Journal:  Brain       Date:  2006-11-22       Impact factor: 13.501

6.  Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion.

Authors:  Teng-nan Lin; Gyoeng-Moon Kim; Jean-Ju Chen; Wai-Mui Cheung; Yong Y He; Chung Y Hsu
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

7.  MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.

Authors:  Anna Rosell; Eloy Cuadrado; Arantxa Ortega-Aznar; Mar Hernández-Guillamon; Eng H Lo; Joan Montaner
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

8.  Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF.

Authors:  Susan Maclauchlan; Eleni A Skokos; Azin Agah; Jianmin Zeng; Weiming Tian; Jeffrey M Davidson; Paul Bornstein; Themis R Kyriakides
Journal:  J Histochem Cytochem       Date:  2008-11-24       Impact factor: 2.479

9.  The role of astrocyte-secreted matricellular proteins in central nervous system development and function.

Authors:  Cagla Eroglu
Journal:  J Cell Commun Signal       Date:  2009-11-11       Impact factor: 5.782

10.  Thrombospondins function as regulators of angiogenesis.

Authors:  Paul Bornstein
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more
  12 in total

Review 1.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

2.  Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2.

Authors:  Susan MacLauchlan; Jun Yu; Marcus Parrish; Tara A Asoulin; Michael Schleicher; Marie M Krady; Jianmin Zeng; Paul L Huang; William C Sessa; Themis R Kyriakides
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 3.  Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.

Authors:  Hema Kumari Alajangi; Mandeep Kaur; Akanksha Sharma; Sumedh Rana; Shipali Thakur; Mary Chatterjee; Neha Singla; Pradeep Kumar Jaiswal; Gurpal Singh; Ravi Pratap Barnwal
Journal:  Mol Brain       Date:  2022-06-01       Impact factor: 4.399

4.  Nanoparticle-based evaluation of blood-brain barrier leakage during the foreign body response.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  J Neural Eng       Date:  2013-01-21       Impact factor: 5.379

5.  The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation.

Authors:  Andrew J Sawyer; Weiming Tian; Jennifer K Saucier-Sawyer; Paul J Rizk; W Mark Saltzman; Ravi V Bellamkonda; Themis R Kyriakides
Journal:  Biomaterials       Date:  2014-05-29       Impact factor: 12.479

6.  Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes.

Authors:  Ellen Phamduong; Maanjot K Rathore; Nicholas R Crews; Alexander S D'Angelo; Andrew L Leinweber; Pranay Kappera; Thomas M Krenning; Victoria R Rendell; Mariana M Belcheva; Carmine J Coscia
Journal:  ACS Chem Neurosci       Date:  2013-12-05       Impact factor: 4.418

7.  Overview and introduction: the blood-brain barrier in health and disease.

Authors:  N Joan Abbott; Alon Friedman
Journal:  Epilepsia       Date:  2012-11       Impact factor: 5.864

8.  Early Tranexamic Acid Administration After Traumatic Brain Injury Is Associated With Reduced Syndecan-1 and Angiopoietin-2 in Patients With Traumatic Intracranial Hemorrhage.

Authors:  Taylor N Anderson; Holly E Hinson; Elizabeth N Dewey; Elizabeth A Rick; Martin A Schreiber; Susan E Rowell
Journal:  J Head Trauma Rehabil       Date:  2020 Sep/Oct       Impact factor: 3.117

9.  Improved HCN channels in pyramidal neurons and their new expression levels in pericytes and astrocytes in the gerbil hippocampal CA1 subfield following transient ischemia.

Authors:  Joon Ha Park; Dae Won Kim; Tae-Kyeong Lee; Cheol Woo Park; Young Eun Park; Ji Hyeon Ahn; Hyang-Ah Lee; Moo-Ho Won; Choong-Hyun Lee
Journal:  Int J Mol Med       Date:  2019-09-26       Impact factor: 4.101

Review 10.  Delineation of candidate genes responsible for structural brain abnormalities in patients with terminal deletions of chromosome 6q27.

Authors:  Sirisha Peddibhotla; Sandesh C S Nagamani; Ayelet Erez; Jill V Hunter; J Lloyd Holder; Mary E Carlin; Patricia I Bader; Helene M F Perras; Judith E Allanson; Leslie Newman; Gayle Simpson; LaDonna Immken; Erin Powell; Aaron Mohanty; Sung-Hae L Kang; Pawel Stankiewicz; Carlos A Bacino; Weimin Bi; Ankita Patel; Sau W Cheung
Journal:  Eur J Hum Genet       Date:  2014-04-16       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.